Clarithromycin and amoxicillin susceptibility of Helicobacter pylori strains isolated from adult patients with gastric or duodenal ulcer in Italy

Current Microbiology

Volumn 40, Issue 2, 2000, Pages 96-100

  Franzin, Laura ^a   Pennazio, Marco ^b   Cabodi, Daniela ^a   Rossini, Francesco Paolo ^b   Gioannini, Paolo ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH SALT; CLARITHROMYCIN; OMEPRAZOLE;

ADULT; AGAR GEL DIFFUSION; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DUODENUM ULCER; FEMALE; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; ITALY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STOMACH ULCER;

ADOLESCENT; ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, MICROBIAL; DUODENAL ULCER; FEMALE; HELICOBACTER PYLORI; HUMANS; ITALY; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PENICILLINS; STOMACH ULCER;

EID: 0033981330     PISSN: 03438651     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002849910018     Document Type: Article

References (34)

1. Alarcón T, Domingo D, Sánchez I, Díaz de Rojas F, López-Brea M (1996) In vitro activity of omeprazole in combination with several antimicrobial agents against clinical isolates of Helicobacter pylori. Eur J Clin Microbiol Infect Dis 15:937-940
2. Buck GE, Smith JS (1987) Medium supplementation for growth of Campylobacter pyloridis. J Clin Microbiol 25:597-599
3. DeCross AJ, Marshall BJ, McCallum RW, Hoffman SR, Barrett LJ, Guerrant RL (1993) Metronidazole susceptibility testing for Helicobacter pylori: comparison of disk, broth and agar dilution methods and their clinical relevance. J Clin Microbiol 31:1971-1974
4. Dent JC, McNulty CAM (1988) Evaluation of a new selective medium for Campylobacter pylori. Eur J Clin Microbiol Infect Dis 7:555-558
5. Dunn BE, Cohen H, Blaser MJ (1997) Helicobacter pylori. Clin Microbiol Rev 10:720-741
6. Eurogast Study Group (1993) An international association between Helicobacter pylori infection and gastric cancer. Lancet 341:1359-1362
7. Gibson JR, Slater E, Xerry J, Tompkins DS, Owen RJ (1998) Use of an amplified-fragment length polymorphism technique to fingerprint and differentiate isolates of Helicobacter pylori. J Clin Microbiol 36:2580-2585
8. Goodwin CS, Armstrong JA (1990) Microbiological aspects of Helicobacter pylori (Campylobacter pylori). Eur J Clin Microbiol Infect Dis 9:1-13
9. Goodwin CS, Armstrong JA, Marshall BJ (1986) Campylobacter pyloridis, gastritis and peptic ulceration. J Clin Pathol 39:353-365
10. Glupczynski Y (1996) Culture of Helicobacter pylori from gastric biopsies and antimicrobial susceptibility testing. In: Lee A, Mégraud F (eds.) Helicobacter pylori: techniques for clinical diagnosis and basic research. London: Saunders Company, pp 17-32
11. Glupzcynski Y, Labbé M, Hansen W, Crokaert F, Yourassowsky E (1991) Evaluation of E-test for quantitative antimicrobial susceptibility testing of Helicobacter pylori. J Clin Microbiol 29:2072-2075
12. Glupczynski Y, Langenberg W, Dankert J, the European Study Group on Antibiotic Susceptibility of Helicobacter pylori (1992) Results of a multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis 11:777-781
13. Hazell SL, Mitchell HM, Hanna G, Daskalopoulos G (1997) Influence of a proton pump inhibitor-based therapy on Helicobacter pylori strain selection. Eur J Clin Microbiol Infect Dis 16:530-532
14. Hirschl AM, Richter M, Makristathis A. Prückl PM, Willinger B, Schütze K, Rotter ML (1994) Single and multiple strain colonization in patients with Helicobacter pylori-associated gastritis: detection by macrorestriction DNA analysis. J Infect Dis 170:473-475
15. Hopkins RJ, Girardi LS, Turney EA (1996) Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 110:1244-1252
16. Logan RPH, Walker MM, Misiewicz JJ, Gummett PA, Karim QN, Baron JH (1994) Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut 36: 12-16
17. Malanoski GJ, Eliopoulos GM, Ferraro MJ, Moellering RC Jr (1993) Effect of pH variation on the susceptibility of Helicobacter pylori to three macrolide antimicrobial agents and temafloxacin. Eur J Clin Microbiol Infect Dis 12:131-133
18. Mégraud F(1997a) Problèmes posés par la résistance de Helicobacter pylori aux antibiotiques. La Presse Médicale 26:1775-1780
19. Mégruad F (1997b) How should Helicobacter pylori infection be diagnosed? Gastroenterology 113:S93-98
20. Mégruad F (1997c) A growing demand for Helicobacter pylori culture in the near future? Ital J Gastroenterol Hepatol 29:574-576
21. Mégraud F, Doermann HP (1998) Clinical relevance of resistant strains of Helicobacter pylori: a review of current data. Gut 43 (Suppl. 1):S61-S65
22. NIH Consensus Conference (1994) Helicobacter pylori in peptic ulcer disease. JAMA 272:65-69
23. Occhialini A, Urdaci M, Doucet-Populaire F, Bebear CM, Lamouliatte H, Mégraud F (1997) Macrolide resistance in Helicobacter pylori: rapid detection of point mutations and assay of macrolide binding to ribosomes. Antimicrob Agents Chemother 41:2724-2728
24. Peterson WL, Graham DY, Marshall B, Blaser MJ, Genta RM, Klein PD, Stratton CW, Drnec J, Prokocimer P, Siepman N (1993) Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. Am J Gastroenterol 88:1860-1864
25. Piccolomini R, Di Bonaventura G, Catamo G, Carbone F, Neri M (1997) Comparative evaluation of the E test, agar diluition, and broth microdiluition for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents. J Clin Microbiol 35:1842-1846
26. Pina M, Occhialini A, Monteiro L, Doermann H-P, Mégraud F (1998) Detection of point mutations associated with resistance of Helicobacter pylori to clarithromycin by hybridization in liquid phase. J Clin Microbiol 36:3285-3290
27. Queirot DMM, Mendes EN, Rocha GA (1987) Indicator medium for isolation of Campylobacter pylori. J Clin Microbiol 25:2378-2379
28. Shortridge VD, Stone GG, Flamm RK, Beyer J, Versalovic J, Graham DW, Tanaka SK (1997) Molecular typing of Helicobacter pylori isolates from a multicenter U.S. clinical trail by ureC restriction fragment length polymorphism. J Clin Microbiol 35:471-473
29. Soll AH (1996) Consensus statement. Medical treatment of peptic ulcer disease. Practice guidelines. JAMA 275:622-629
30. Taylor NS, Fox JG, Akopyants NS, Berg DE, Thompson N, Shames B, Yan L, Fontham E, Janney F, Hunter FM, Correa P (1995) Long-term colonization with single and multiple strains of Helicobacter pylori assessed by DNA fingerprinting. J Clin Microbiol 33:918-923
31. van Zwet AA, de Boer WA, Schneeberger PM, Weel J, Jansz AR, Thijs JC (1996) Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in The Netherlands. Eur J Clin Microbiol Infect Dis 15:861-864
32. van Zwet AA, Vandenbrouke-Grauls CMJE, Thijs JC, van der Wouden EJ, Gerrits MM, Kusters JG (1998) Stable amoxicillin resistance in Helicobacter pylori. Lancet 352:1595
33. Versalovic J, Shortridge D, Kibler K, Griffy MV, Beyer J, Flamm RK, Tanaka SK, Graham DY, Go MF (1996) Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother 40:477-480
34. Wang GE, Jiang Q, Taylor DE (1998) Genotypic characterization of clarithromycin-resistant and -susceptible Helicobacter pylori strains from the same patient demonstrates existence of two unrelated isolates. J Clin Microbiol 36:2730-2731